Floatz logo

Therapeutic Asset Ratings

1,027 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Loncastuximab Tesirine
Diffuse Large B-Cell Lymphoma
Universität MünsterP2CCC (55)
Loncastuximab Tesirine
Marginal Zone Lymphoma
University of MiamiP2CCC (55)
Loncastuximab Tesirine
Primary Mediastinal Large B-Cell Lymphoma
City of Hope Medical CenterP2CCC (55)
rc48
Non-Small Cell Lung Carcinoma
Sun Yat-sen UniversityP2CCC (55)
rc48-adc
Follicular Lymphoma
Tianjin Medical University Cancer Institute and HospitalP2CCC (55)
rc48-adc
Immunotherapy
Anbogen Therapeutics, Inc.P2CCC (55)
rc48-adc
Mesothelioma
HiFiBiO TherapeuticsP2CCC (55)
rc48-adc
Pancreatic Adenocarcinoma
Indaptus Therapeutics, IncP2CCC (55)
rc48-adc
Sarcoma
HiFiBiO TherapeuticsP2CCC (55)
Sacituzumab Tirumotecan
Ovarian Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.P2CCC (55)
T-Dxd
Metastatic Malignant Neoplasm In The Brain
Iambic Therapeutics, IncP2CCC (55)
Trastuzumab Deruxtecan
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P2CCC (55)
Trastuzumab Duocarmazine
Triple-Negative Breast Carcinoma
QuantumLeap Healthcare CollaborativeP2CCC (55)
Trastuzumab Emtansine
Advanced Cancer
University Health Network, TorontoP2CCC (55)
Trastuzumab Emtansine
Metastatic Malignant Neoplasm In The Brain
M.D. Anderson Cancer CenterP2CCC (55)
Trastuzumab Emtansine
Solid Tumor
Seoul National University Bundang HospitalP2CCC (55)
Trastuzumab Emtansine
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)P2CCC (55)
Antibody drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE
Cancer
LaNova Australia Pty LimitedP1/2CCC (55)
Brentuximab Vedotin
Adolescent
Children's Cancer Group, ChinaP2/3CCC (55)
Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide
Castration-Resistant Prostate Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P2/3CCC (55)
Ifinatamab Deruxtecan
Prostate Neoplasm
Merck Sharp & Dohme LLCP3CCC (54)
Immunoglobulin G1 [240-alanine,241-alanine], anti-(human folate receptor ?) (human monoclonal PRO1184 ?1-chain, complex with human monoclonal PRO1184 ?-chain, dimer, 214??,214???,226,226?,232,232?,235,235?-octakis(thioether) with N6-[39-[bis(1-deoxy-D-glucitol-1-yl)amino]-1-oxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxanonatriacont-1-yl]-N2-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-lysyl-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]methyl]phenyl]-L-ornithinamide
Ovarian Cancer
GenmabP3CCC (54)
Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide
Ovarian Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3CCC (54)
Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide
Primary Peritoneal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3CCC (54)
Inotuzumab Ozogamicin
Mixed Phenotype Acute Leukemia
Children's Oncology GroupP3CCC (54)
Showing 251 to 275 of 1,027 assets
PreviousPage 11 of 42Next